-
Founded in:
2012-06-26 -
Country:
China -
Address:
No. 69, Renhe Xingguang Avenue, Yubei District, Chongqing -
Tax NO.:
915000005992299001 -
Registered Funds:
450 million yuan -
Website:
-
Email:
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| Desonide |
This product is a glucocorticoid drug with anti-inflammatory, anti-allergic, antipruritic and exudation-reducing effects; it can reduce and prevent tissue response to inflammation, eliminate fever, redness and swelling caused by local non-infectious inflammation, thereby reducing the manifestations of inflammation; it has an immunosuppressive effect of preventing or inhibiting cellular immune responses and suppressing primary immune responses.
More
This product is a glucocorticoid drug with anti-inflammatory, anti-allergic, antipruritic and exudation-reducing effects; it can reduce and prevent tissue response to inflammation, eliminate fever, redness and swelling caused by local non-infectious inflammation, thereby reducing the manifestations of inflammation; it has an immunosuppressive effect of preventing or inhibiting cellular immune responses and suppressing primary immune responses. |
638-94-8 | 14 |
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| Nimesulide |
This product is a non-steroidal anti-inflammatory drug with anti-inflammatory, analgesic and antipyretic effects. Its mechanism of action is not yet fully understood, but it may be mainly related to the inhibition of prostaglandin synthesis, mediator release of leukocytes and oxidative reactions of polymorphonuclear leukocytes.
More
This product is a non-steroidal anti-inflammatory drug with anti-inflammatory, analgesic and antipyretic effects. Its mechanism of action is not yet fully understood, but it may be mainly related to the inhibition of prostaglandin synthesis, mediator release of leukocytes and oxidative reactions of polymorphonuclear leukocytes. |
51803-78-2 | 14 |
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| Nimesulide |
This product is a non-steroidal anti-inflammatory drug with anti-inflammatory, analgesic and antipyretic effects. Its mechanism of action is not yet fully understood, but it may be mainly related to the inhibition of prostaglandin synthesis, mediator release of leukocytes and oxidative reactions of polymorphonuclear leukocytes.
More
This product is a non-steroidal anti-inflammatory drug with anti-inflammatory, analgesic and antipyretic effects. Its mechanism of action is not yet fully understood, but it may be mainly related to the inhibition of prostaglandin synthesis, mediator release of leukocytes and oxidative reactions of polymorphonuclear leukocytes. |
51803-78-2 | 14 |
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| Artemether |
It has a strong and rapid killing effect on the erythrocytic stage of malarial parasites and can quickly control clinical attacks and symptoms. Its mechanism of action is mainly to interfere with the function of the surface membrane-mitochondria of malarial parasites, affect the ultrastructure of the erythrocytic stage of malarial parasites, block the nutritional intake of malarial parasites, and generate unstable organic free radicals and other electrophilic mediators mediated by the free iron produced after the decomposition of hemoglobin through the endoperoxide bridge, forming covalent adducts with malarial parasite proteins and causing the death of malarial parasites.
More
It has a strong and rapid killing effect on the erythrocytic stage of malarial parasites and can quickly control clinical attacks and symptoms. Its mechanism of action is mainly to interfere with the function of the surface membrane-mitochondria of malarial parasites, affect the ultrastructure of the erythrocytic stage of malarial parasites, block the nutritional intake of malarial parasites, and generate unstable organic free radicals and other electrophilic mediators mediated by the free iron produced after the decomposition of hemoglobin through the endoperoxide bridge, forming covalent adducts with malarial parasite proteins and causing the death of malarial parasites. |
71963-77-4 | 14 |
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| Retinoic acid |
This product is a tumor cell differentiation inducer that can not only maintain the differentiation of normal epithelial cells, but also differentiate leukemia cells into blood cells with normal phenotypic functions, and can inhibit cancer cell proliferation in vitro.
More
This product is a tumor cell differentiation inducer that can not only maintain the differentiation of normal epithelial cells, but also differentiate leukemia cells into blood cells with normal phenotypic functions, and can inhibit cancer cell proliferation in vitro. |
302-79-4 | 12 |